Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Wedbush starts Curaleaf with Outperform, expects share gains » 16:15
12/01/22
12/01
16:15
12/01/22
16:15
CURLF

Curaleaf

$7.02 /

+0.4 (+6.04%)

Wedbush analyst Gerald…

Wedbush analyst Gerald Pascarelli initiated coverage of Curaleaf with an Outperform rating and $8.50 price target. Curaleaf is the largest U.S. cannabis operator and should be well positioned to realize incremental benefits from the rollout of adult use sales in new states in addition to benefiting from better performance in its many legacy markets, Pascarelli tells investors in a research note. He expects the company to be a net share gainer and outpace the broad industry.

ShowHide Related Items >><<
CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

12/01/22 Wedbush
Curaleaf initiated with an Outperform at Wedbush
11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

Initiation
Curaleaf initiated with an Outperform at Wedbush » 16:04
12/01/22
12/01
16:04
12/01/22
16:04
CURLF

Curaleaf

$7.02 /

+0.4 (+6.04%)

Wedbush analyst Gerald…

Wedbush analyst Gerald Pascarelli initiated coverage of Curaleaf with an Outperform rating and $8.50 price target.

ShowHide Related Items >><<
CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

CURLF Curaleaf
$7.02 /

+0.4 (+6.04%)

On The Fly
Rising High: Exclusive talk with cannabis REIT NewLake Capital » 09:46
11/25/22
11/25
09:46
11/25/22
09:46
NLCP

NewLake Capital Partners

$17.96 /

+1.16 (+6.90%)

, AYRWF

Ayr Wellness

$2.91 /

+0.044 (+1.53%)

, CURLF

Curaleaf

$6.70 /

+0.114 (+1.73%)

, ACB

Aurora Cannabis

$1.32 /

+ (+0.00%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$3.50 /

+0.01 (+0.29%)

, CRON

Cronos Group

$3.05 /

-0.02 (-0.65%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

/

+

, GTBIF

Green Thumb Industries

$13.29 /

+0.39 (+3.02%)

, IGC

India Globalization Capital

/

+

, TLRY

Tilray

$3.75 /

-0.025 (-0.66%)

, TCNNF

Trulieve Cannabis

$13.00 /

+0.82 (+6.73%)

, ZYNE

Zynerba

/

+

, ATAI

Atai Life Sciences

$3.16 /

-0.015 (-0.47%)

, CMPS

Compass Pathways

$10.48 /

-0.1 (-0.95%)

, RLMD

Relmada Therapeutics

$5.33 /

+0.09 (+1.72%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

TCNNF Trulieve Cannabis
$13.00 /

+0.82 (+6.73%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$13.29 /

+0.39 (+3.02%)

GDNSF Goodness Growth
/

+

CVSI CV Sciences
/

+

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

CANN General Cannabis
/

+

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

10/06/22 Ladenburg
NewLake Capital price target lowered to $27.50 from $29 at Ladenburg
08/09/22 Ladenburg
NewLake Capital Partners price target lowered to $29.50 from $38 at Ladenburg
03/21/22 Ladenburg
NewLake Capital price target lowered to $39.50 from $44 at Ladenburg
AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

10/28/22 BTIG
Ayr Wellness initiated with a Buy at BTIG
08/19/22 Canaccord
Ayr Wellness price target lowered to C$30 from C$40 at Canaccord
08/19/22 Northland
Ayr Wellness price target lowered to $10 from $14 at Northland
08/19/22 Canaccord
Ayr Wellness price target lowered to C$30 from C$40 at Canaccord
CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

11/09/22 Bernstein
Two more states legalize cannabis, $3B added to TAM, says Bernstein
09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
CVSI CV Sciences
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CTST CannTrust
/

+

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

11/07/22 Canaccord
Canopy Growth price target raised to C$5 from C$4.25 at Canaccord
11/01/22 Bernstein
Bernstein starts Canopy Growth at Underperform, sees equity raise
11/01/22 Bernstein
Canopy Growth initiated with an Underperform at Bernstein
CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

11/08/22 Canaccord
Cronos Group price target lowered to C$4.75 from C$5 at Canaccord
11/01/22 Bernstein
Cronos started with Market Perform on limited visibility at Bernstein
11/01/22 Bernstein
Cronos Group initiated with a Market Perform at Bernstein
CANN General Cannabis
/

+

GDNSF Goodness Growth
/

+

11/16/22 Canaccord
Goodness Growth price target lowered to C$0.85 from C$1 at Canaccord
10/14/22 Alliance Global Partners
Verano Holdings price target lowered to C$12 from C$16 at Alliance Global
05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
GTBIF Green Thumb Industries
$13.29 /

+0.39 (+3.02%)

11/03/22 Stifel
Green Thumb Industries price target raised to C$31 from C$30.50 at Stifel
10/28/22 BTIG
Green Thumb Industries assumed with a Buy at BTIG
IGC India Globalization Capital
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

11/01/22 Bernstein
Tilray initiated with Market Perform, $3.90 target at Bernstein
11/01/22 Bernstein
Tilray initiated with a Market Perform at Bernstein
TCNNF Trulieve Cannabis
$13.00 /

+0.82 (+6.73%)

11/10/22 Canaccord
Trulieve Cannabis price target lowered to C$50 from C$54 at Canaccord
10/28/22 BTIG
Trulieve Cannabis assumed with a Buy at BTIG
ZYNE Zynerba
/

+

06/23/22 Canaccord
Zynerba price target raised to $11 from $9 at Canaccord
ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
10/13/22 Oppenheimer
Compass Pathways price target lowered to $55 from $65 at Oppenheimer
10/13/22 Canaccord
Compass Pathways price target lowered to $50 from $78 at Canaccord
08/05/22 Cantor Fitzgerald
Compass Pathways price target lowered to $35 from $58 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
ZYNE Zynerba
/

+

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

NLCP NewLake Capital Partners
$17.96 /

+1.16 (+6.90%)

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CRON Cronos Group
$3.05 /

-0.02 (-0.65%)

CMPS Compass Pathways
$10.48 /

-0.1 (-0.95%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ATAI Atai Life Sciences
$3.16 /

-0.015 (-0.47%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

  • 27
    May
  • 09
    Dec
CVSI CV Sciences
/

+

CURLF Curaleaf
$6.70 /

+0.114 (+1.73%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

AYRWF Ayr Wellness
$2.91 /

+0.044 (+1.53%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

TLRY Tilray
$3.75 /

-0.025 (-0.66%)

RLMD Relmada Therapeutics
$5.33 /

+0.09 (+1.72%)

CGC Canopy Growth
$3.50 /

+0.01 (+0.29%)

ACB Aurora Cannabis
$1.32 /

+ (+0.00%)

Hot Stocks
Curaleaf opens two new Florida dispensaries » 08:14
11/22/22
11/22
08:14
11/22/22
08:14
CURLF

Curaleaf

$6.40 /

-0.14 (-2.14%)

Curaleaf Holdings…

Curaleaf Holdings announced the opening of two new Florida dispensaries, Orlando International Drive and Miami South Beach. The new locations are Curaleaf's 53rd and 54th locations to open in the Sunshine State and 144th nationwide.

ShowHide Related Items >><<
CURLF Curaleaf
$6.40 /

-0.14 (-2.14%)

CURLF Curaleaf
$6.40 /

-0.14 (-2.14%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
CURLF Curaleaf
$6.40 /

-0.14 (-2.14%)

CURLF Curaleaf
$6.40 /

-0.14 (-2.14%)

Hot Stocks
Curaleaf announces strategic national rebrand of Grassroots » 08:10
11/14/22
11/14
08:10
11/14/22
08:10
CURLF

Curaleaf

$6.32 /

+0.192223 (+3.14%)

Curaleaf Holdings…

Curaleaf Holdings announced the national rebrand of its Grassroots premium cannabis flower brand, and shared details on the brand's previously announced expansion into California with the launch of Diamond Infused Pre-Rolls. The rebrand of Grassroots coincides with the launch of its Grower's Reserve program, an ongoing series of limited-edition collaborations with craft farmers and diverse operators in California.

ShowHide Related Items >><<
CURLF Curaleaf
$6.32 /

+0.192223 (+3.14%)

CURLF Curaleaf
$6.32 /

+0.192223 (+3.14%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
CURLF Curaleaf
$6.32 /

+0.192223 (+3.14%)

CURLF Curaleaf
$6.32 /

+0.192223 (+3.14%)

Hot Stocks
Tilt Holdings enters manufacture, distribution agreement with Curaleaf » 08:17
11/09/22
11/09
08:17
11/09/22
08:17
TLLTF

Tilt Holdings

/

+

, CURLF

Curaleaf

$5.52 /

+0.17 (+3.18%)

TILT Holdings announced…

TILT Holdings announced Jupiter Research has entered into an exclusive five-year manufacture, supply and distribution agreement with Curaleaf International to bring the Jupiter manufactured Liquid Que vaporizer to new territories abroad, for use as a medical device with extracts developed by Curaleaf International, subject to obtaining regulatory approvals in the relevant territories. Introduced in 2020, the Liquid Que vaporizer is the first independent pod system to be manufactured by Jupiter Research. Featuring a snap-in pod cartridge, magnetic connection, and rechargeable power supply, the Liquid Que's cutting-edge design preserves the integrity of high-viscosity extracts at every stage. Jupiter Research will be Curaleaf International's exclusive supplier of all vaporizer hardware, cartridges, and related accessories including the Liquid Que, for use with liquid medical cannabis products, bringing it initially to the United Kingdom and European Union, with other territories such as Switzerland, Norway, Australia, Israel, and the United Arab Emirates to follow. Curaleaf International will in turn develop each market, coordinate approval of the formulations and extracts in each territory per local regulations and distribute the approved Liquid Que device in these markets exclusively. The Liquid Que is expected to reach the UK beginning in late 2023.

ShowHide Related Items >><<
TLLTF Tilt Holdings
/

+

CURLF Curaleaf
$5.52 /

+0.17 (+3.18%)

TLLTF Tilt Holdings
/

+

CURLF Curaleaf
$5.52 /

+0.17 (+3.18%)

11/08/22 Stifel
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel
10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
CURLF Curaleaf
$5.52 /

+0.17 (+3.18%)

CURLF Curaleaf
$5.52 /

+0.17 (+3.18%)

Recommendations
Curaleaf price target lowered to C$8.50 from C$9.50 at Stifel » 11:50
11/08/22
11/08
11:50
11/08/22
11:50
CURLF

Curaleaf

$5.35 /

-0.19 (-3.43%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou lowered the firm's price target on Curaleaf to C$8.50 from C$9.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
08/09/22 Alliance Global Partners
Curaleaf price target lowered to C$12 from C$15 at Alliance Global Partners
CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

Over a month ago
Earnings
Curaleaf reports Q3 EPS (7c), consensus (4c) » 16:04
11/07/22
11/07
16:04
11/07/22
16:04
CURLF

Curaleaf

$5.35 /

-0.19 (-3.43%)

Reports Q3 revenue…

Reports Q3 revenue $339.73M, consensus $337.99M.

ShowHide Related Items >><<
CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

10/28/22 BTIG
Curaleaf assumed with a Buy at BTIG
10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
08/09/22 Alliance Global Partners
Curaleaf price target lowered to C$12 from C$15 at Alliance Global Partners
CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

CURLF Curaleaf
$5.35 /

-0.19 (-3.43%)

Initiation
Curaleaf assumed with a Buy at BTIG » 08:15
10/28/22
10/28
08:15
10/28/22
08:15
CURLF

Curaleaf

$5.35 /

-0.18 (-3.25%)

BTIG analyst Jonathan…

BTIG analyst Jonathan DeCourcey assumed coverage of Curaleaf with a Buy rating and C$10 price target. Curaleaf is the largest multi-state operator in U.S. cannabis and is "poised to benefit from that standing," DeCourcey tells investors in a research note. The analyst says Curaleaf has an established presence in every U.S. state market that does or will matter in the near term while recently having developed an early presence in potential large scale European markets "that could one day offer significant growth."

ShowHide Related Items >><<
CURLF Curaleaf
$5.35 /

-0.18 (-3.25%)

CURLF Curaleaf
$5.35 /

-0.18 (-3.25%)

10/07/22 Stifel
Cannabis stocks could rise about three times in near-term, says Stifel
08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
08/09/22 Alliance Global Partners
Curaleaf price target lowered to C$12 from C$15 at Alliance Global Partners
08/09/22 Cowen
Curaleaf price target lowered to $10 from $25 at Cowen
CURLF Curaleaf
$5.35 /

-0.18 (-3.25%)

CURLF Curaleaf
$5.35 /

-0.18 (-3.25%)

Recommendations
Cannabis stocks could rise about three times in near-term, says Stifel » 08:33
10/07/22
10/07
08:33
10/07/22
08:33
CRLBF

Cresco Labs

$3.30 /

+0.6457 (+24.37%)

, CURLF

Curaleaf

$6.19 /

+1.54 (+33.12%)

, GTBIF

Green Thumb Industries

$13.15 /

+3.06 (+30.33%)

, TRSSF

TerrAscend

$1.68 /

+0.33 (+24.44%)

, TCNNF

Trulieve Cannabis

$11.99 /

+3.1755 (+36.02%)

, ACB

Aurora Cannabis

$1.30 /

+0.05 (+4.02%)

, CGC

Canopy Growth

$3.76 /

+0.695 (+22.71%)

, CRON

Cronos Group

$3.36 /

+0.39 (+13.15%)

, TLRY

Tilray

$3.89 /

+0.92 (+30.98%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou notes yesterday's "surprise announcement" from President Biden of three executive actions surrounding cannabis pardons and initiating a review on cannabis scheduling, calling this "the most important development in US cannabis history since the Cole Memo." The most near term impact could be passing the SAFE Act, most likely through the NDAA in the lame duck session, and as a result he sees cannabis company shares "having the potential to increase up to 3x from current levels in short order." In the longer-term, dependent on scheduling outcomes, 280E could be addressed, which he sees having the potential to improve operating cash flows by 50%-250% for companies he covers in the space, Partheniou tells investors, adding "we could be on the cusp of a secular cannabis bull market." Stocks he covers that could be beneficiaries include Cresco Labs (CRLBF), Curaleaf (CURLF), Green Thumb Industries (GTBIF), TerrAscend (TRSSF) and Trulieve Cannabis (TCNNF). Other stocks in the space include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON) and Tilray (TLRY).

ShowHide Related Items >><<
TRSSF TerrAscend
$1.68 /

+0.33 (+24.44%)

TLRY Tilray
$3.89 /

+0.92 (+30.98%)

TCNNF Trulieve Cannabis
$11.99 /

+3.1755 (+36.02%)

GTBIF Green Thumb Industries
$13.15 /

+3.06 (+30.33%)

CURLF Curaleaf
$6.19 /

+1.54 (+33.12%)

CRON Cronos Group
$3.36 /

+0.39 (+13.15%)

CRLBF Cresco Labs
$3.30 /

+0.6457 (+24.37%)

CGC Canopy Growth
$3.76 /

+0.695 (+22.71%)

ACB Aurora Cannabis
$1.30 /

+0.05 (+4.02%)

CRLBF Cresco Labs
$3.30 /

+0.6457 (+24.37%)

08/18/22 Canaccord
Cresco Labs price target lowered to C$8 from C$9.50 at Canaccord
08/18/22 Piper Sandler
Cresco Labs price target lowered to $6 from $9 at Piper Sandler
08/17/22 Alliance Global Partners
Cresco Labs price target lowered to C$10 from C$15 at Alliance Global Partners
05/19/22 Canaccord
Cresco Labs price target lowered to C$9.50 from C$12 at Canaccord
CURLF Curaleaf
$6.19 /

+1.54 (+33.12%)

08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
08/09/22 Alliance Global Partners
Curaleaf price target lowered to C$12 from C$15 at Alliance Global Partners
08/09/22 Cowen
Curaleaf price target lowered to $10 from $25 at Cowen
07/22/22 Seaport Global
Curaleaf initiated with a Buy at Seaport Global
GTBIF Green Thumb Industries
$13.15 /

+3.06 (+30.33%)

08/04/22 Canaccord
Green Thumb Industries price target lowered to C$35 from C$40 at Canaccord
08/04/22 Stifel
Green Thumb Industries price target raised to C$30.50 from C$30 at Stifel
08/04/22 Alliance Global Partners
Green Thumb Industries price target lowered to C$25 at Alliance Global Partners
08/04/22 Cantor Fitzgerald
Green Thumb Industries price target lowered to $31 from $39 at Cantor Fitzgerald
TRSSF TerrAscend
$1.68 /

+0.33 (+24.44%)

09/12/22 Canaccord
TerrAscend initiated with a Buy at Canaccord
08/15/22 Cowen
TerrAscend price target lowered to $4.50 from $9 at Cowen
08/12/22 Stifel
TerrAscend price target lowered to C$5.50 from C$6 at Stifel
08/12/22 Craig-Hallum
TerrAscend downgraded to Hold from Buy at Craig-Hallum
TCNNF Trulieve Cannabis
$11.99 /

+3.1755 (+36.02%)

08/11/22 Canaccord
Trulieve Cannabis price target lowered to C$57 from C$65 at Canaccord
08/11/22 Stifel
Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel
08/11/22 Craig-Hallum
Trulieve Cannabis price target lowered to $32 from $40 at Craig-Hallum
08/11/22 Cowen
Trulieve Cannabis price target lowered to $24 from $65 at Cowen
ACB Aurora Cannabis
$1.30 /

+0.05 (+4.02%)

09/21/22 Canaccord
Aurora Cannabis upgraded to Hold from Sell at Canaccord
09/21/22 Piper Sandler
Aurora Cannabis price target lowered to $3 from $4 at Piper Sandler
06/24/22 Cantor Fitzgerald
Cantor upgrades Aurora to Overweight on potential catalyst in Germany
06/24/22 Cantor Fitzgerald
Aurora Cannabis upgraded to Overweight from Neutral at Cantor Fitzgerald
CGC Canopy Growth
$3.76 /

+0.695 (+22.71%)

09/30/22 Barclays
Canopy Growth price target lowered to $2 from $3.50 at Barclays
08/08/22 Canaccord
Canopy Growth price target lowered to C$2.75 from C$3.50 at Canaccord
08/08/22 Piper Sandler
Canopy Growth price target lowered to $2.50 from $3 at Piper Sandler
07/01/22 Canaccord
Canopy Growth price target lowered to C$3.50 from C$4.50 at Canaccord
CRON Cronos Group
$3.36 /

+0.39 (+13.15%)

09/30/22 Barclays
Cronos Group price target lowered to $3.50 from $5 at Barclays
07/28/22 Canaccord
Cronos Group upgraded to Buy from Hold at Canaccord
05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
TLRY Tilray
$3.89 /

+0.92 (+30.98%)

09/30/22 Barclays
Tilray price target lowered to $2 from $4.50 at Barclays
07/29/22 Cowen
Tilray price target lowered to $9 from $23 at Cowen
07/29/22 Benchmark
Tilray cut to Sell at Benchmark on continued deterioration in core business
07/29/22 Benchmark
Tilray downgraded to Sell from Hold at Benchmark
TLRY Tilray
$3.89 /

+0.92 (+30.98%)

TCNNF Trulieve Cannabis
$11.99 /

+3.1755 (+36.02%)

CURLF Curaleaf
$6.19 /

+1.54 (+33.12%)

CRON Cronos Group
$3.36 /

+0.39 (+13.15%)

CGC Canopy Growth
$3.76 /

+0.695 (+22.71%)

ACB Aurora Cannabis
$1.30 /

+0.05 (+4.02%)

  • 27
    May
CURLF Curaleaf
$6.19 /

+1.54 (+33.12%)

GTBIF Green Thumb Industries
$13.15 /

+3.06 (+30.33%)

CURLF Curaleaf
$6.19 /

+1.54 (+33.12%)

CRLBF Cresco Labs
$3.30 /

+0.6457 (+24.37%)

ACB Aurora Cannabis
$1.30 /

+0.05 (+4.02%)

TLRY Tilray
$3.89 /

+0.92 (+30.98%)

CGC Canopy Growth
$3.76 /

+0.695 (+22.71%)

ACB Aurora Cannabis
$1.30 /

+0.05 (+4.02%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.